peroxynitrous acid has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 9,156 | 187 | 552 |
| Protein | Taxonomy | peroxynitrous acid (IC50) | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Homo sapiens (human) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connelly, PW; Draganov, D; Maguire, GF | 1 |
1 review(s) available for peroxynitrous acid and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.
Topics: Animals; Antioxidants; Aryldialkylphosphatase; Humans; Lipid Metabolism; Oxygen; Peroxynitrous Acid; Phosphatidylcholines; Phospholipids; Phosphorylation; Platelet Activating Factor; Time Factors | 2005 |